TegoScience Inc - Asset Resilience Ratio

Latest as of June 2026: 52.34%

TegoScience Inc (191420) has an Asset Resilience Ratio of 52.34% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See TegoScience Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩39.98 Billion

≈ $27.09 Million USD Cash + Short-term Investments

Total Assets

₩76.38 Billion

≈ $51.76 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how TegoScience Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 191420 asset base.

Liquid Assets Composition Over Time

This chart breaks down TegoScience Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore TegoScience Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩39.98 Billion	52.34%
Total Liquid Assets	₩39.98 Billion	52.34%

Asset Resilience Insights

Very High Liquidity: TegoScience Inc maintains exceptional liquid asset reserves at 52.34% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

TegoScience Inc Industry Peers by Asset Resilience Ratio

Compare TegoScience Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
GeneBioTech Co. Ltd KQ:086060	Pharmaceuticals	22.68%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	6.87%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Oscotec Inc KQ:039200	Pharmaceuticals	65.38%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Komipharm International Co. Ltd KQ:041960	Pharmaceuticals	0.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%

Annual Asset Resilience Ratio for TegoScience Inc (2015–2025)

The table below shows the annual Asset Resilience Ratio data for TegoScience Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	49.64%	₩38.80 Billion ≈ $26.29 Million	₩78.16 Billion ≈ $52.97 Million	-2.42pp
2024-12-31	52.06%	₩27.34 Billion ≈ $18.53 Million	₩52.52 Billion ≈ $35.59 Million	+9.30pp
2023-12-31	42.76%	₩20.91 Billion ≈ $14.17 Million	₩48.91 Billion ≈ $33.15 Million	-0.67pp
2022-12-31	43.43%	₩22.31 Billion ≈ $15.12 Million	₩51.36 Billion ≈ $34.81 Million	+1.65pp
2021-12-31	41.78%	₩21.31 Billion ≈ $14.44 Million	₩51.00 Billion ≈ $34.56 Million	-3.79pp
2020-12-31	45.58%	₩22.97 Billion ≈ $15.57 Million	₩50.40 Billion ≈ $34.16 Million	-0.32pp
2019-12-31	45.90%	₩22.29 Billion ≈ $15.11 Million	₩48.57 Billion ≈ $32.91 Million	+22.22pp
2018-12-31	23.67%	₩11.26 Billion ≈ $7.63 Million	₩47.56 Billion ≈ $32.23 Million	+1.76pp
2017-12-31	21.92%	₩10.43 Billion ≈ $7.07 Million	₩47.59 Billion ≈ $32.25 Million	-23.31pp
2016-12-31	45.22%	₩20.19 Billion ≈ $13.68 Million	₩44.64 Billion ≈ $30.25 Million	+33.58pp
2015-12-31	11.65%	₩3.00 Billion ≈ $2.03 Million	₩25.76 Billion ≈ $17.46 Million	--

pp = percentage points

About TegoScience Inc

KQ:191420 Korea Pharmaceuticals

Market Cap

$41.48 Million

₩61.21 Billion KRW

Market Cap Rank

#22683 Global

#1473 in Korea

Share Price

₩7580.00

Change (1 day)

+4.26%

52-Week Range

₩5600.00 - ₩18970.00

All Time High

₩71600.00